BioAmber Sarnia Secures $10 Million Interest Free Loan From Agriculture Canada

BioAmber Sarnia Secures $10 Million Interest Free Loan From Agriculture Canada 
The loan is a significant milestone for the Sarnia plant and contributes 
important capital 
All amounts are in Canadian dollars. 
SARNIA, ON, Feb. 19, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE and EURONEXT 
Paris: BIOA), an industrial biotechnology company producing sustainable 
chemicals, today announced that its subsidiary BioAmber Sarnia Inc. has 
secured a $10 million interest free loan from Agriculture Canada for the 
30,000 MT succinic acid plant currently under construction in Sarnia, Ontario, 
Canada. The loan, which was secured through the Department's Agri-Innovation 
Program, will be reimbursable in equal yearly installments from 2015 to 2024. 
The loan was officially announced today by Minister Gerry Ritz, at an event 
that took place in Sarnia. The event was also attended by senior 
representatives of Mitsui & Co., BioAmber's partner in the Sarnia plant, and 
other government officials at the local, provincial and federal levels.  The 
event took place on the construction site of the Sarnia plant and showcased 
the progress being made. 
BioAmber Sarnia had previously received $35 million in support from government 
organizations including Sustainable Development Technology Canada, the Federal 
Economic Development Agency for Southern Ontario and the Ontario Ministry of 
Economic Development, Trade and Employment. 
"We are very appreciative of the support that the Agri-Innovation Program has 
provided to our Sarnia plant," said Jean-Francois Huc, BioAmber's Chief 
Executive Officer. "This is a great example of how government can support 
Canadian farmers, create jobs and reinvigorate the manufacturing sector, while 
also making a meaningful contribution to climate change," he added. 
"Our government remains focused on creating new opportunities for Canadian 
farmers and businesses to grow and prosper. BioAmber's innovative project will 
help enhance the bottom line of producers by using a corn derivative as 
agricultural feedstock while generating jobs in the Sarnia area," said 
Canada's Agriculture Minister Gerry Ritz. 
"We are actively negotiating additional loans for Sarnia that will further 
ease the investment burden for BioAmber, which is an early stage company.  Our 
goal is to get Sarnia operational in early 2015 and these loans will help 
ensure that we have the capital needed to ramp up production and become a 
profitable company," added Mike Hartmann, BioAmber's Executive Vice President. 
About BioAmber 
BioAmber (NYSE and EURONEXT Paris: BIOA) is an industrial biotechnology 
company producing sustainable chemicals. Its proprietary technology platform 
combines industrial biotechnology and chemical catalysis to convert renewable 
feedstock into sustainable chemicals for use in a wide variety of everyday 
products including plastics, resins, food additives and personal care 
products. For more information visit 
Forward-Looking Statements 
This press release contains forward-looking statements, including statements 
related to the timing of the completion of our planned facility, our goal of 
securing additional loans and becoming a profitable company.   All statements 
other than statements of historical fact contained in this press release are 
forward-looking statements.  These statements often include words such as 
"believe," "expect," "anticipate," "intend," "plan," "estimate," "seek," 
"will," "may" or similar expressions. Forward-looking statements are subject 
to a number of risks and uncertainties, many of which involve factors or 
circumstances that are beyond BioAmber's control. BioAmber's actual results 
could differ materially from those stated or implied in forward-looking 
statements due to a number of factors, including but not limited to, risks 
detailed in BioAmber's most recent registration statement on Form S-1 filed 
with the Securities and Exchange Commission, as well as other documents that 
may be filed by the Company from time to time with the Securities and Exchange 
Commission. In particular, the following factors, among others, could cause 
results to differ materially from those expressed or implied by such 
forward-looking statements: the Company's limited operating history, the 
inability of the Company to execute on its manufacturing expansion strategy, 
including the construction of our planned facility in Sarnia, Ontario, the 
inability of the Company to comply with milestone covenants contained in 
certain of its agreements, the Company's limited sales of bio-succinic acid to 
date, the Company's inability to obtain additional financing, the Company's 
inability to leverage its bio-succinic acid technology to develop and 
commercialize derivatives of bio-succinic acid and other bio-based building 
block chemicals, and a decrease in demand for bio-succinic acid, bio-based 1,4 
BDO and other bio-succinic acid derivatives.  Although we believe that the 
expectations reflected in the forward-looking statements are reasonable, we 
cannot guarantee that the events and circumstances reflected in the 
forward-looking statements will be achieved or occur and the timing of events 
and circumstances and actual results could differ materially from those 
projected in the forward-looking statements. Accordingly, you should not place 
undue reliance on these forward-looking statements. All such statements speak 
only as of the date made, and we undertake no obligation to update or revise 
publicly any forward-looking statements, whether as a result of new 
information, future events or otherwise.

SOURCE  BioAmber Inc. 
BioAmber Investor Contact 
Michael Rice LifeSci Advisors, LLC 1350 Avenue of the Americas 28th Floor New 
York, NY 10019 646-597-6979 
To view this news release in HTML formatting, please use the following URL: 
CO: BioAmber Inc.
ST: Ontario
-0- Feb/19/2014 21:15 GMT
Press spacebar to pause and continue. Press esc to stop.